Quality of Life and Functional Status After Revascularization or Conservative Treatment in Patients With Intermittent Claudication

Abstract

Revascularization of patients with intermittent claudication (IC) is recommended only for selected patients who have chronic pain or disabling disease. However, improvement in the quality of life (QoL) could justify more widespread use.

Objectives: To determine the effect of conservative treatment and revascularization on the QoL and physical performance of selected patients with IC.

Patients and Methods: This nonrandomized, parallel group, follow-up study included 83 patients with IC at Fontaine stage II. On the basis of interventional opportunities and the risks and benefits, combined with the preference of the patient, 47 patients were treated conservatively and 41 were revascularized. The patients were examined at inclusion and 3 months later. The evaluations included the QoL measure Short Form 36 (SF-36), the Walking Impairment Questionnaire (WIQ), pain-free and maximal walking distance (treadmill at 3 km/h, no incline), maximal isometric knee-extension strength and endurance, and ankle—brachial blood pressure index (ABI).

Results: At baseline, the SF-36 and WIQ scores and the ABI were significantly lower in the patients selected for revascularization. After revascularization, all dimensions of QoL and functional status increased significantly in the patients who underwent revascularisation compared with the patients treated conservatively. The difference in the change in the physical component summary of SF-36 was 29.4% (P < .001), in the total WIQ 63.6% (P = .0002), and in the pain-free and maximal walking distances 313% (P < .001) and 135% (P < .001), respectively. After adjustment for age, smoking, ABI, body mass index (BMI), and baseline values, the differences remained statistically significant.

Conclusion: Revascularization above the knee increased QoL, functional status, and walking distance significantly in patients with moderate IC.

Keywords

claudication vascular surgery quality of life mobility limitation

Get full access to this article

View all access options for this article.

References

Taft C. , Sullivan M. , Lundholm K. , Karlsson J. , Gelin J. , Jivegard L. Predictors of treatment outcome in intermittent claudication. Eur J Vasc Endovasc Surg. 2004;27(1):24-32.

Chi YW , Jaff MR Optimal risk factor modification and medical management of the patient with peripheral arterial disease. Catheter Cardiovasc Interv . 2008;71(4):475-489.

Momsen AH , Jensen MB , Norager CB , Madsen MR , Vestersgaard-Andersen TB , Lindholt JS Drug therapy for improving walking distance in intermittent claudication. A systematic review and meta-analysis of robust randomized controlled studies . Eur J Vasc Endovasc Surg. 2009;38(4):463-474.

Murphy TP , Soares GM , Kim HM , Ahn SH , Haas RA Quality of life and exercise performance after aortoiliac stent placement for claudication. J Vasc Interv Radiol. 2005 ;16(7):947-953.

Norgren L. , Hiatt WR , Dormandy JA , Nehler MR , Harris KA , Fowkes FG Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007; 45(supplS):S5-S67.

Hirsch AT , Haskal ZJ , Hertzer NR , et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006;113(11):e463-e654.

Pell JP , Lee AJ Impact of angioplasty and arterial reconstructive surgery on the quality of life of claudicants. The Scottish Vascular Audit Group. Scott Med J. 1997;42(2):47-48.

Mori E. , Komori K. , Kume M. , et al. Comparison of the long-term results between surgical and conservative treatment in patients with intermittent claudication. Surgery . 2002;131(suppl 1): S269-S274.

Vogel TR , Su LT , Symons RG , Flum DR Lower extremity angioplasty for claudication: a population-level analysis of 30-day outcomes. J Vasc Surg. 2007;45(4):762-767.

10.

Momsen AH , Jensen BJ , Norager CB , Madsen MR , Vestersgaard-Andersen T. , Lindholt JS Caffeine improves walking distance in patients with intermittent claudication. A randomized, double-blind, placebo-controlled crossover study. Br J Surg. 2010. IN PRESS.

11.

McDermott MM , Greenland P. , Liu K. , et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study . Ann Intern Med. 2002 ; 136(12):873-883.

12.

Verspaget M. , Nicolai SP , Kruidenier LM , Welten RJ , Prins MH , Teijink JA Validation of the Dutch version of the Walking Impairment Questionnaire. Eur J Vasc Endovasc Surg. 2009; 37(1):56-61.

13.

Rantanen T. , Era P. , Heikkinen E. Physical activity and the changes in maximal isometric strength in men and women from the age of 75 to 80 years. J Am Geriatr Soc. 1997;45(12): 1439-1445.

14.

Bosch JL , van der GY , Hunink MG Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation . 1999; 99(24):3155-3160.

15.

Beebe HG Intermittent claudication: effective medical management of a common circulatory problem. Am J Cardiol. 2001; 87(12A):14D-18D.

16.

Perkins JM , Collin J. , Creasy TS , Fletcher EW , Morris PJ Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg. 1996;11(4):409-413.

17.

Regensteiner JG , Meyer TJ , Krupski WC , Cranford LS , Hiatt WR Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease . Angiology. 1997;48(4): 291-300.

18.

Regensteiner JG , Gardner A. , Hiatt WR Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997. Vasc Med. 1997;2(2):147-155.

19.

Watson L. , Ellis B. , Leng GC Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008;4: CD000990.

20.

Tan KH , Cotterrell D. , Sykes K. , Sissons GR , de CL , Edwards PR Exercise training for claudicants: changes in blood flow, cardiorespiratory status, metabolic functions, blood rheology and lipid profile. Eur J Vasc Endovasc Surg. 2000; 20(1):72-78.

21.

Lumsden AB , Rice TW Medical management of peripheral arterial disease: a therapeutic algorithm . J Endovasc Ther. 2006; 13(suppl2):1119-1129.

22.

Mehta T. , Venkata SA , Chetter I. , McCollum P. Disease-specific quality of life assessment in intermittent claudication: review. Eur J Vasc Endovasc Surg. 2003;25(3):202-208.

23.

Izquierdo-Porrera AM , Gardner AW , Bradham DD , et al. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. J Vasc Surg. 2005; 41(4):625-630.

24.

de VM , Ouwendijk R. , Kessels AG , et al. Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease . J Vasc Surg. 2005;41(2):261-268.

25.

Hiatt WR , Cox L. , Greenwalt M. , Griffin A. , Schechter C. Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials. Vasc Med. 2005;10(3): 207-213.

26.

Labs KH , Nehler MR , Roessner M. , Jaeger KA , Hiatt WR Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol. Vasc Med. 1999;4(4):239-246.

27.

Regensteiner JG Exercise in the treatment of claudication: assessment and treatment of functional impairment. Vasc Med . 1997;2(3):238-242.

28.

Izquierdo-Porrera AM , Gardner AW , Powell CC , Katzel LI Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease . J Vasc Surg. 2000;31(4):670-677.

29.

Myers SA , Johanning JM , Stergiou N. , Lynch TG , Longo GM , Pipinos II Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease. J Vasc Surg. 2008; 47(3):550-555.

30.

Breek JC , De VJ , van Heck GL , van Berge Henegouwen DP , Hamming JF Assessment of disease impact in patients with intermittent claudication: discrepancy between health status and quality of life. J Vasc Surg. 2005;41(3):443-450.

31.

Aquarius AE , Denollet J. , Hamming JF , Breek JC , De VJ Impaired health status and invasive treatment in peripheral arterial disease: a prospective 1-year follow-up study. J Vasc Surg. 2005;41(3):436-442.

32.

Kugler CF , Rudofsky G. Do age and comorbidity affect quality of life or PTA-induced quality-of-life improvements in patients with symptomatic pad? J Endovasc Ther. 2005;12(3):387-393.

33.

McDermott MM , Ades P. , Guralnik JM , et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301(2):165-174.

34.

Spronk S. , Bosch JL , den Hoed PT , Veen HF , Pattynama PM , Hunink MG Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg. 2008;48(6):1472-1480.

35.

Daenens K. , Schepers S. , Fourneau I. , Houthoofd S. , Nevelsteen A. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. J Vasc Surg. 2009;49(5):1210-1216.